Jump to content

CAP COM.30450


jalomahe

Recommended Posts

No we don't. We use the FMH Rapid Screen kit and it contains a positive and negative control. If I am reading the standard correctly, it says you can use QC materials to validate the lot so I think we are good to go with the built in controls with each lot. Feel free to "argue" this with me if you think we would get a deficiency from CAP. Thanks

Link to comment
Share on other sites

Me again, if JC expects lot to lot verification on ALL kits, how do we compare new to old kits for fetal cell stain kits? We make up our own positive control as instructed and would do the same thing for the new kit. So how would we verify a new kit? Either the control works with the new set of stains or it doesn't. Any ideas other than using the same exact control preparation on both the old and new kit?

Link to comment
Share on other sites

To meet CAP COM.30450, we parallel new lot vs old lot for both Fetal Screen and Fetal Stain kits.

Fetal screen: "Perform testing of the new lot using controls from the current "in use" lot and the new lot."

Fetal stain: We prepare our own positive and negative controls.  When we parallel we use the same set of positive and negative controls and test the new and current "in use" lot against the controls.

Link to comment
Share on other sites

Do you think this also applies to other reagents such as Anti-A, Anti-D, Anti-K, etc.? One of the other hospitals in town was cited for not performing a comparison on these too. I guess we will be starting this as soon as I can wrap my brain around it. I don't want to go thru the ordeal of having to address this after an inspection. My opinion is these reagents must meet FDA potency requirements. That seems like a higher calling to me than testing known cells against these one time when they arrive. We also do controls each day of use. If they don't work, we can't trust them.

 

What about panels and screening cells? Yes, you can test a known antibody patient with old and new screening cells and panels to compare that particular antibody but that doesn't cover all possible antigens on the cells. How can you test that?

 

This seems like a waste of tech time and resources to me. Who thinks up these things? It can't be a person that actually knows blood bank. This is not chemistry where we have to make sure the results of a new lot # are in a particular range. It either works or it doesn't. The patient is either positive or not. My 2 cents.

 

If others are doing this, please let us know how you are satisfying this requirement.

Link to comment
Share on other sites

For forward and reverse typing reagents, unless you change the control lot and a reagent lot at the same time, you ARE doing a lot-to-lot when you start using a new reagent lot.

 

Regarding QCing AB panels used for AB ID, there have been discussions about this here before.  Some labs test a new panel at the begin and end of its useable life, some only towards the end, and some not at all.  Some test several types of antisera, others only one, like a hetero Fya or an Rh.

 

Scott.

Link to comment
Share on other sites

 

This seems like a waste of tech time and resources to me. Who thinks up these things? It can't be a person that actually knows blood bank. This is not chemistry where we have to make sure the results of a new lot # are in a particular range. It either works or it doesn't. The patient is either positive or not. My 2 cents.

 

If others are doing this, please let us know how you are satisfying this requirement.

 

I totally agree with you, DebbieL!!

 

Donna

Link to comment
Share on other sites

I have an update for this thread. I went to the source and called CAP and a blood bank person called me back. This is what I got out of the conversation regarding COM.30450. This deals mostly with kits.

 

1. We need to compare the current fetal screen kit to the new fetal screen kit. This can be done by using the current kit's pos/neg/indicator cells with the new kit to compare.

 

2. We need to compare the current Elu-kit to the new Elu-kit. (!!??!) Unfortunately, this will involve performing and eluate on a patient with the current kit and then performing another eluate on the same patient with the new kit. :( Two eluates in the same patient. This means I will order more kits at a time to cut the number of times this has to be done.

 

3. If you run out of a reagent during the day and have to use a new lot number, that reagent must be QC'd.

 

4. As part of your daily QC on your rack of reagents, you can use one indate antisera to make sure the screening cells work. Anti-D, Anti-K, etc.

 

5. We do not have to compare new lot numbers to current lot numbers on rare antisera. It is a waste of expensive antisera.

 

Sanity reigns!

 

 

 

Link to comment
Share on other sites

Uggh!

 

Ok.  So if I do an elution and the eluate is non reactive with all cells tested on both kits, is that a correlation?  Or, if the eluate is reactive with all cells tested???

 

I cannot remember the last time that we eluted anything clinically significant.  Luckily that doesn't happen very often!!

 

Is this like trying to validate a test system using ALL antibodies for correlation?  Sure, I have a frozen Diego b from 25 years ago!!!

 

:)

 

Thanks for your investigation and information!

Link to comment
Share on other sites

I agree Uggh!

 

We started the Fetal Bleed lot to lot this summer but did not do the Elu kit.

 

The only thing we have that would be positive is the Survey and that does not give us enough to do twice in tube....  I would say all most all of the patients we do are all positive or all negative and we only do about 10 a year....  may be better to send these patients to the reference lab, but then out turn around time will stink..

 

 

 

 

I have an update for this thread. I went to the source and called CAP and a blood bank person called me back. This is what I got out of the conversation regarding COM.30450. This deals mostly with kits.

 

1. We need to compare the current fetal screen kit to the new fetal screen kit. This can be done by using the current kit's pos/neg/indicator cells with the new kit to compare.

 

2. We need to compare the current Elu-kit to the new Elu-kit. (!!??!) Unfortunately, this will involve performing and eluate on a patient with the current kit and then performing another eluate on the same patient with the new kit. :( Two eluates in the same patient. This means I will order more kits at a time to cut the number of times this has to be done.

 

3. If you run out of a reagent during the day and have to use a new lot number, that reagent must be QC'd.

 

4. As part of your daily QC on your rack of reagents, you can use one indate antisera to make sure the screening cells work. Anti-D, Anti-K, etc.

 

5. We do not have to compare new lot numbers to current lot numbers on rare antisera. It is a waste of expensive antisera.

 

Sanity reigns!

Link to comment
Share on other sites

Well it likes like I'm OK for everything but the Elu-Kit.

 

How about this for elutions. Add a few drops of anti-D (or whatever) to a couple of mLs of Rh pos cells, do an elution on both samples. Then test both eluates with selected cells to prove you got anti-D - I'm thinking that a 3 cell antibody screen would do the trick. Quicker that way than running a full panel and it would show reactivity and non-reactivity appropriate to the antibody.

Link to comment
Share on other sites

We have been doing elutions off of check cells for individual competency. I suppose we could be doing the same for lot verification. Since we do most of our testing in gel, we have an ample supply of coombs control check cells, which show an anti-D.

Link to comment
Share on other sites

fETAL BLEED KIT: HOW ABOUT RUNNING POSITIVE AND NEGATIVE CONTROLS RUNNING FROM OLD AND RUNNING POSITIVE AND NEGATIVE CONTROLS RUNNING FROM NEW KIT SAME TIME???

 

This is what we've been doing for years when we receive our new fetal bleed kits. Cells from old kit + antisera from new kit and cells from new kit + antisera from old kit.

Edited by AMcCord
Link to comment
Share on other sites

For blood bank antisera and reagent cells QC, we do lot to lot comparison using QC material.  The comparisons do not need to be the SAME day.  We use Ortho Confidence kit and we stagger the shipments so that we are not putting new lots of reagent cells and QC material on the same day.  So when bringing in a new lot of antisera or reagent cells we perform QC using the SAME lot of QC that we used YESTERDAY to QC our previous lot.  So yesterday old lot was QC'd with in use QC kit and today new lot QC'd with in use QC kit.  This is no extra work as you obviously have to QC the new lot before putting it into use anyway.  We drew the line at doing this for our rare antisera which we may not have used for days/week/months so no way to run the same control material and I am so glad to see CAP is not requiring this.  Eluate kit parallel is a real bummer though!

Edited by Sandy L
Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
  • Recently Browsing   0 members

    • No registered users viewing this page.
  • Advertisement

×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.